Comparing Early and Late Onset Colorectal Cancer Patients
Official title: Early-Onset Colorectal Cancer Versus Late-Onset Colorectal Cancer: a Prospective Observational Cohort Study to Explore the Clinical, Sociodemographic, Genetic, and Molecular Characteristics Associated With Adverse Oncological Outcomes (
Run by Istituto Clinico Humanitas · NCT06326879 · Data updated 2026-11-12
This study looks at the differences between younger and older patients with colorectal cancer to see why younger patients might have a tougher time after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 340 (estimated) |
| Sponsor | Istituto Clinico Humanitas Academic / other |
| Locations | 1 site (Rozzano, MI) |
| Status | Recruiting |
| Started | November 30, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | October 30, 2027 |
| Registry record updated | March 25, 2024 |
| Trial ID | NCT06326879 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with a confirmed diagnosis of colorectal adenocarcinoma at stages I-III who are scheduled for elective curative surgery.
✕Probably not a fit
Patients with metastatic colorectal cancer or those requiring emergency or palliative procedures will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the differences in clinical, socioeconomic, behavioral, genetic, and molecular factors between patients diagnosed with Early Onset Colorectal Cancer (EOCRC) before age 50 and those diagnosed with Late Onset Colorectal Cancer (LOCRC) after age 50. The study aims to validate previous findings regarding the higher recurrence rates of colorectal cancer in EOCRC patients and explore associations with various factors affecting postoperative survival. By collecting data through questionnaires and biological samples, the study seeks to provide insights into the aggressive nature of EOCRC and its underlying causes.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management strategies for patients with Early Onset Colorectal Cancer.
How similar studies have gone: While studies on colorectal cancer exist, this specific comparative approach focusing on early versus late onset is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged more than 18 years old at the time of inclusion. * Patients with a proven diagnosis of colorectal adenocarcinoma, as reported by the staging histological biopsies. * Patients with a preoperative staging I-III. * Patients scheduled for elective curative colorectal resection. * Patients with rectal cancer who underwent neoadjuvant therapy can be included in the study. * Patients able and willing to comply with the protocol requirements (samples' collection and questionnaires' compilation). Exclusion Criteria: * Patients with metastatic disease at diagnosis. * Patients requiring an emergent procedure. * Patients undergoing palliative surgery (for example, fecal diversion). * Patients with a surgical indication for benign lesions (for example, adenoma or dysplasia). * Patients with an intraoperative finding of a lesion other than adenocarcinoma will be withdrawn from the study. * Patients with an intraoperative finding of distal metastasis or peritoneal carcinosis will be withdrawn from the study. * Patients with a concomitant diagnosis of Inflammatory Bowel Disease. * Patients with a known genetic syndrome (for example, Lynch syndrome or Familial Adenomatous Polyposis).
Where it's running
-
IRCCS Humanitas Research Hospital
Rozzano, Mi, Italy Recruiting
Study contacts
- Principal investigator: Antonino Spinelli, MD, PhD — IRCCS Huamanitas Research Hospital
- Study coordinator: Annalisa Maroli, PhD
- Email: colorapp@humanitas.it
- Phone: 02 8224 7776
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
-
LTZ-232: a first-in-human test in advanced colorectal and other solid tumors
A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.